Predictive Prioritization of Enhancers Associated with Pancreas Disease RiskH. Efsun Arda(National Institutes of Health)bioRxiv (Cold Spring Harbor Laboratory)September 13, 202410.1101/2024.09.07.611794Cited by 3SaveCiteExport RISWatch citationsRelated PapersDiet-Induced Developmental Acceleration Independent of TOR and Insulin in C. elegans|Cell|2013|336A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis|Development|2017|32eLife Assessment: Large-scale analysis of the integration of enhancer-enhancer signals by promoters|Unknown|2023|0Author response: Hippo pathway-mediated YAP1/TAZ inhibition is essential for proper pancreatic endocrine specification and differentiation|Unknown|2024|0